Q1 FY27 results reported
As filed · Outcome of Board Meeting
EarningsMajormateriality 75 out of 100
What happened
FactUnaudited Financial Results of the Company for the quarter ended 30th June 2026. the Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June. The above Un-Audited Financial Results are also available on the website of the Company i.e.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
WithdrawnEarlierQ1 FY27
FY26-27 Guidance Exports Contribution 25%-30%
NowQ1 FY27
However, we will be able to -- having the current scenario, we think that we may cross that number.
Change
FactGuidance withdrawn
Implication
CapitSignal interpretationThe earlier statement provided a specific guidance of 25%-30% for exports contribution, while the current statement suggests uncertainty and implies that the previous target may not be met.confidence 90%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- FY26-27 Guidance EBITDA Margin 14%-15% (management committed by FY27)
- FY26-27 Guidance Revenue Growth 15%-20% (management committed by FY27)
Evidence
- IOL Chemicals and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%